Comparison
Aase Smith Syndrome C0220686 vs Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
Clinical comparison between Aase Smith Syndrome and Abnormal Amplitude OF Light Adapted Single Flash Electroretinogram for differential diagnosis and treatment planning.
Aase Smith Syndrome C0220686
A rare condition characterized by skeletal abnormalities including joint contractures, hydrocephalus, and anemia. Treatment focuses on managing bone and joint problems, addressing hydrocephalus if present, and supportive care.
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
An electroretinogram finding indicating abnormal electrical responses from retinal cone cells. It may signal retinal disease and typically requires further eye examination.
6 comparison axes
Onset
Aase Smith Syndrome C0220686
0-0
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
Variable
Onset patterns differ
Severity
Aase Smith Syndrome C0220686
moderate
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
moderate
Different severity levels
Chronic
Aase Smith Syndrome C0220686
Chronic
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
Chronic
Differing course
Communicable
Aase Smith Syndrome C0220686
No
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
No
Different transmission
Body System
Aase Smith Syndrome C0220686
congenital
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
ophthalmologic
Same/different system
Category
Aase Smith Syndrome C0220686
genetic
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
genetic
Different category
Bottom line
aase-smith-syndrome-C0220686 and abnormal-amplitude-of-light-adapted-single-flash-electroretinogram-C4072971 have similar characteristics
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Aase Smith Syndrome C0220686 | Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971 | Discriminating power |
|---|---|---|---|
| Main presentation | Congenital skeletal abnormalities, joint contractures, possible hydrocephalus and anemia. | Abnormal cone-cell electrical response on a light-adapted single-flash ERG. | High |
| Clinical meaning | A syndromic condition requiring assessment of multiple congenital problems. | A test abnormality that may suggest retinal disease but does not establish one. | High |
| Onset | Congenital, with features present from birth or early development. | Variable timing, depending on the underlying eye condition. | Moderate |
When to favor each condition
Choose Aase Smith Syndrome C0220686 when
An infant has congenital contractures, skeletal anomalies, anemia, or hydrocephalus.
This multisystem pattern matches the supplied syndrome description better than an isolated ERG result.
Moderate
The clinical question concerns a congenital developmental condition.
The syndrome is categorized as congenital and genetic, not as a single eye measurement.
Moderate
Supportive care for bones, joints, anemia, or hydrocephalus is being planned.
Management is problem-specific; exact treatment details are not established here.
Low
Choose Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971 when
An ERG report specifically describes abnormal light-adapted single-flash amplitude.
The concept directly names that electrophysiology finding.
High
The concern is cone-pathway retinal function.
The supplied description links the result to retinal cone responses.
Moderate
No congenital skeletal, hematologic, or hydrocephalus features are described.
An isolated eye-test abnormality should not be labeled as the syndrome.
Moderate
How key tests differ
| Test | Aase Smith Syndrome C0220686 | Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971 | Interpretation |
|---|---|---|---|
| Clinical examination | May identify contractures, skeletal anomalies, or signs suggesting hydrocephalus. | Eye examination is appropriate, but the syndrome is not defined by it. | Examination context separates a multisystem syndrome from a retinal test finding. |
| Blood count | Anemia may be present; no cutoff is supplied. | A blood count does not define the ERG abnormality. | Hematologic testing supports syndrome evaluation only when clinically indicated. |
| Light-adapted single-flash ERG | No characteristic ERG pattern is established in the supplied data. | Abnormal cone-response amplitude is present by definition. | The result warrants ophthalmic interpretation and is not a syndrome diagnosis. |
Prognosis comparison
Aase Smith Syndrome C0220686
- Outcome
- The course is described as chronic, but individual outcome is not established.
- Factors
- Extent of skeletal problems, anemia, hydrocephalus, and supportive care.
Abnormal Amplitude Of Light Adapted Single Flash Electroretinogram C4072971
- Outcome
- Course depends on the unidentified cause of the retinal abnormality.
- Factors
- Underlying eye condition, associated findings, and follow-up.
Time frame: Variable; no reliable timeline is supplied.
Clinician assessment should guide expectations for both concepts.
Complications comparison
| Complication | Presentation |
|---|---|
| Hydrocephalus | May occur and requires clinical assessment. Not described as part of the ERG finding. A shared neurologic complication should not be assumed. |
| Anemia | Described as a feature of the syndrome. Not established by the ERG result. Blood abnormalities need separate confirmation. |
| Retinal disease | Not established by the supplied syndrome description. May signal retinal disease and requires further eye evaluation. The finding is a clue, not proof of a specific diagnosis. |
Patient education highlights
- HighDifferent concepts
One is a rare congenital syndrome; the other is an abnormal eye-test result.
- HighNeed for interpretation
An abnormal ERG amplitude requires clinician review and may lead to further eye examination.
- MediumCare expectations
Syndrome care is supportive and tailored to identified problems; outcomes and doses are not established here.